newsfilter
← Latest News
Business Wire·

4D pharma to Participate in Jefferies Virtual Next Generation IBD Therapeutics Summit

4D pharma plc (AIM: DDDD, NASDAQ, LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that 4D management will present at the Jefferies Virtual